← Leaderboards
Samuel Singer
Sloan-Kettering Inst Can Research
$8,089,401
Attributed
$8,408,151
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,837,717 · 11
By mechanism
P50$34,077,924 · 8
P01$10,334,793 · 2
S10$425,000 · 1
Top collaborators
- Scott Keeney1 shared
- Eric C Lai1 shared
- Agnes Viale1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Craig B Thompson$56,520,903
- Andrea Ventura$13,315,692
- Mithat Gonen$8,869,475
- Mengmeng Du$2,352,665
- Benjamin A Nacev$1,365,320
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineCollaborationsSarcomaDatabasesProgramsMolecularTumorSignal PathwayLinkComplexPathway InteractionsResearch PersonnelNew Therapeutic TargetClinical TrialsDiagnosisGenomicsSoft Tissue SarcomaTranslational ResearchBaseStructureGeneticMalignant Fibrous HistiocytomaMyxoid Malignant Fibrous HistiocytomaMolecular Genetics
Grant awards (49)
SPORE in Soft Tissue Sarcoma$2,453,831
P50 · FY2025 · CA · contact PI
Project 2: Targeting the Hippo Pathway in Genetically Complex Sarcomas$573,661
P50 · FY2025 · CA · contact PI
Administrative Core$192,887
P50 · FY2025 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,375,406
P50 · FY2024 · CA · contact PI
Project 2: Targeting the Hippo Pathway in Genetically Complex Sarcomas$550,537
P50 · FY2024 · CA · contact PI
Administrative Core$185,111
P50 · FY2024 · CA · contact PI
Singer SPORE Supplement$918,606
P50 · FY2023 · CA · contact PI
Targeting Oncogenic Pathways in Genetically Complex Sarcomas$275,582
P50 · FY2023 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,126,450
P50 · FY2022 · CA · contact PI
Targeting Oncogenic Pathways in Genetically Complex Sarcomas$416,456
P50 · FY2022 · CA · contact PI
Administrative Core$163,863
P50 · FY2022 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,126,450
P50 · FY2021 · CA · contact PI
Targeting Oncogenic Pathways in Genetically Complex Sarcomas$416,455
P50 · FY2021 · CA · contact PI
Administrative Core$163,865
P50 · FY2021 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,170,212
P50 · FY2020 · CA · contact PI
Targeting Oncogenic Pathways in Genetically Complex Sarcomas$420,832
P50 · FY2020 · CA · contact PI
Administrative Core$168,238
P50 · FY2020 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,126,449
P50 · FY2019 · CA · contact PI
Targeting Oncogenic Pathways in Genetically Complex Sarcomas$402,188
P50 · FY2019 · CA · contact PI
Administrative Core$167,279
P50 · FY2019 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,286,505
P50 · FY2018 · CA · contact PI
Targeting Oncogenic Pathways in Genetically Complex Sarcomas$432,461
P50 · FY2018 · CA · contact PI
Administrative Core$179,869
P50 · FY2018 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,162,000
P50 · FY2014 · CA · contact PI
P3 - Target Discovery In Sarcoma Through Gemone-Wide Genetic and Functional Anal$268,432
P50 · FY2014 · CA · contact PI
Administrative Core$65,197
P50 · FY2014 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,136,282
P50 · FY2013 · CA · contact PI
P3 - Target Discovery In Sarcoma Through Gemone-Wide Genetic and Functional Anal$266,051
P50 · FY2013 · CA · contact PI
Administrative Core$65,202
P50 · FY2013 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,300,000
P50 · FY2012 · CA · contact PI
P3 - Target Discovery In Sarcoma Through Gemone-Wide Genetic and Functional Anal$283,762
P50 · FY2012 · CA · contact PI
Administrative Core$70,186
P50 · FY2012 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,185,000
P50 · FY2011 · CA · contact PI
P3 - Target Discovery In Sarcoma Through Gemone-Wide Genetic and Functional Anal$268,810
P50 · FY2011 · CA · contact PI
Administrative Core$67,115
P50 · FY2011 · CA · contact PI
SPORE in Soft Tissue Sarcoma$2,300,000
P50 · FY2010 · CA · contact PI
Soft Tissue Sarcoma Program Project$1,805,746
P01 · FY2010 · CA · contact PI
ACQUISITION OF A SOLiD 3 SEQUENCER$425,000
S10 · FY2010 · RR
Integrated Molecular and Biochemical Profiling of Liposarcoma Subtypes$366,212
P01 · FY2010 · CA · contact PI
P3 - Target Discovery In Sarcoma Through Gemone-Wide Genetic and Functional Anal$276,896
P50 · FY2010 · CA · contact PI
Administrative Core$69,798
P50 · FY2010 · CA · contact PI
Soft Tissue Sarcoma Program Project$1,776,015
P01 · FY2009 · CA · contact PI
Integrated Molecular and Biochemical Profiling of Liposarcoma Subtypes$358,883
P01 · FY2009 · CA · contact PI
Soft Tissue Sarcoma Program Project$1,729,965
P01 · FY2008 · CA · contact PI
Integrated Molecular and Biochemical Profiling of Liposarcoma Subtypes$348,287
P01 · FY2008 · CA · contact PI
Soft Tissue Sarcoma Program Project$1,718,617
P01 · FY2007 · CA · contact PI
Integrated Molecular and Biochemical Profiling of Liposarcoma Subtypes$344,688
P01 · FY2007 · CA · contact PI
Soft Tissue Sarcoma Program Project$1,732,032
P01 · FY2006 · CA · contact PI
Integrated Molecular and Biochemical Profiling of Liposarcoma Subtypes$154,348
P01 · FY2006 · CA · contact PI